Medical Technology Caucus
This article was originally published in The Gray Sheet
Holding briefing March 21 to discuss the effects on medical technology of each of the major health care proposals currently before Congress. Clifton Gaus of the Agency for Health Policy Research and Kathleen Buto of the Health Care Financing Administration will represent the Clinton plan; David Kehl, legislative director for Rep. Bob Michel (R-Ill.) will speak for the Republican Action Now plan; and William Schulyer, legislative assistant for Sen. Dave Durenburger (R-Minn.), will represent the Cooper/Breaux plan. Representatives of the Nickles/Sterns, McDermott/Wellstone, Chafee, and Stark plans have been invited as wel
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.